Clinical Trial

Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
To develop an educational tool to help patients and healthcare professionals make informed decisions about endometrial cancer and available prevention options for it (such as the use of a levonorgestrel-releasing intrauterine system \[LNG-IUS\]).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-01-28; most recent amendment 2026-02-24.
Status change: Not Yet Recruiting → Recruiting 2026-02-24
Trial Details
NCT Number NCT07382583
Lead Sponsor M.D. Anderson Cancer Center
Collaborators: Cancer Prevention Research Institute of Texas
Conditions Levonorgestrel, Intrauterine Systems, Prevention, Endometrial Cancer
Enrollment 270 participants
Start Date 2026-02-12
Primary Completion 2028-02-01 (estimated)
Study Completion 2030-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-12